South San Francisco, CA May 5, 2015 Submitted by Genentech Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced Futurelab, a collaborative program with the South San Francisco Unified School District (SSFUSD) to support science,…
Tag: Genentech
FDA Grants Genentech’s Cobimetinib Priority Review for Use in Combination with Zelboraf (Vemurafenib) in Advanced Melanoma
South San Francisco, CA February 18, 2015 Press Release Genentech Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for…
Genentech to Present Clinical Data from Six Different Medicines at American Society of Hematology (ASH) Annual Meeting
Presentations include data on Genentech’s broad portfolio of hematology medicines and emerging investigational agents including ACE910 (RG6013) in hemophilia A South San Francisco, Calif. — December 5, 2014 –PRESS RELEASE Genentech, a member of the Roche Group (SIX: RO,…
SSF Holds First Biotechnology Education & Workforce Development Summit
South San Francisco, CA October 30, 2014 Submitted by City of South San Francisco Aiming to inspire students to pursue careers in science and biotechnology, the City of South San Francisco, Genentech, and BayBio hosted the first annual Biotechnology…
FDA Approves Genentech’s Avastin Plus Chemotherapy for Treatment of Advanced Cervical Cancer
South San Francisco, CA August 14, 2014 Submitted by Genentech Press Release SOUTH SAN FRANCISCO, CALIF. — 2014-08-14 Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced…
SSF Youth Receives 120 Bicycles as Part of Giving Back to the Community Week
South San Francisco, CA July 2, 2014 Submitted by City of South San Francisco As part of “Giving Back to the Community Week,” the South San Francisco Fire Department, South San Francisco Firefighters Union Local 1507, San Mateo County…
Genentech Announces Definitive Agreement to Acquire Seragon Pharmaceuticals
SOUTH SAN FRANCISCO, CALIF. — 2014-07-01 Acquisition of Phase I program strengthens Genentech’s oncology pipeline and offers a potential new approach for hormone receptor-positive breast cancer Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today…
SSF Officials to attend 2014 BIO International Convention
South San Francisco, CA June 19, 2014 Submitted by City of South San Francisco Aiming to cement the City’s position as the number one destination for biotech in the United States, officials from the City of South San Francisco…
Genentech to Present New Data on 27 Different Medicines at ASCO
Genentech to Present New Data on 27 Different Medicines at ASCO Genentech to deliver new data on approved medicines, investigational targeted combinations and the emerging pipeline Data in more than 19 tumor types will be presented, including new results from…
Genentech stops METLung Study
Genentech Provides Update On Phase III Study Of Onartuzumab in People With Specific Type of Lung Cancer SOUTH SAN FRANCISCO, CALIF. — 2014-03-02 Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that an independent…